OBJECTIVE： To evaluate the rationality of cancelling drug addition compensation strategy in county-level public hospitals in China， and to provide reference for abolishing the system of “drug-maintaining-medicine”. METHODS： The documents about cancelling drug addition strategy in county-level public hospitals were collected from websites of 30 provincial， autonomous region and municipality （called “province and city” for short） general office and related governmental departments before Aug. 1st， in 2015. The cancelling drug addition strategy in county-level public hospitals was analyzed in respects of rate of progress， compensation mode， compensation radix， compensation range， compensation channel and compensation rate， financial compensation way. RESULTS： 46.67％ provinces and cities completely cancelled drug addition strategy； the compensation mode of canceling drug addition was “how much to cancel，how much to compensate” in the vast majority of provinces and cities； drug addition income financial data in 2011 or the year before cancelling drug addition strategy were used as compensation radix in 54.55％ provinces and cities； compensation way included adjusting medical service price in 93.33％ provinces and cities， government finance compensation in 86.67％， and strengthening hospital cost control and digesting cost by hospital in 50.00％. The rate of financial compensation in provinces and cities which had cancelled drug addition strategy completely was 1.72 times as much as those had not cancelled drug addition strategy completely； the rate of adjusting medical service price in provinces and cities which had not cancelled drug addition strategy completely was 1.22 times as much as those had cancelled drug addition strategy completely. Financial compensation way mainly included compensating by resident population and by performance appraisal result. CONCLUSIONS： The rate of financial compensation is highly positively correlated with rate of progress； compensation channel of adjusting medical service price takes subject responsibility； the situation of cancelling drug addition strategy doesn’t adapt to strategy purpose. It is suggested to establish step by step and classified medical service price adjustment system and local health plan-oriented differentiated financial input mechanism.